Interval pathologic assessments in patients treated with concurrent hyperfractionated radiation and intraarterial cisplatin (HYPERRADPLAT)

Head and Neck

Volumn 24, Issue 6, 2002, Pages 539-544

  Valentino, Joseph ^a,b   Spring, Paul M ^a,b   Shane, Matthew ^b   Arnold, Susanne M ^c   Regine, William F ^d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Cisplatin; Head and neck cancer; Histopathology; Oncology; Radiotherapy

Indexed keywords

CISPLATIN; HYPERADPLAT;

ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EVALUATION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; METABOLIC REGULATION; MOLECULAR DYNAMICS; OBSERVATION; PATHOLOGICAL ANATOMY; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT PLANNING; TUMOR BIOPSY; TUMOR LOCALIZATION; ULCER;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 0036263594     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10096     Document Type: Article

References (12)

1. High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck
2. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: The University of Florida experience
3. Targeted chemoradiation for advanced head and neck cancer: Analysis of 213 patients [in process citation]
4. High-dose intraarterial cisplatin and concurrent hyperfractionated radiation therapy in patients with locally advanced primary squamous cell carcinoma of the head and neck: Report of a phase II study
5. Surgery after organ preservation therapy. Analysis of wound complications
6. Intact tumor cells in irradiated tissue
7. General principles for treatment of cancers of the head and neck: The primary site
8. The significance of "positive" margins in surgically resected epidermoid carcinomas
9. Pattern of invasion and margin assessment in patients with oral tongue cancer
10. Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer
11. Role of dynamic MRI in the evaluation of head and neck cancers treated with radiation therapy
12. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms